This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Elsevier, AcademicCME And ArcheMedX Announce The All-New ThrombosisClinic.com

PHILADELPHIA, April 25, 2013 /PRNewswire/ --

New ThrombosisClinic.com will be the first informatics-powered, connected learning environment for continuing education

Elsevier's Office of Continuing Medical Education (EOCME) announced today that it is extending its existing collaboration with AcademicCME and ArcheMedX to re-launch the ThrombosisClinic.com website. The ArcheMedX connected learning platform will power the new site to create a collaborative learning experience for interdisciplinary teams of clinicians.

"The all-new, ThrombosisClinic.com will be a critical resource designed to reduce mortality and improve outcomes for patients with thromboembolic disease by providing clinicians with a more effective and more efficient lifelong learning solution," said Sandy Breslow, Director of the EOCME. The new site provides a one-of-a-kind educational resource for the entire interdisciplinary clinical team, including physicians, nurse practitioners, physician assistants, nurses, pharmacists and other healthcare providers dedicated to thrombosis prevention, treatment and management.

By delivering advanced education to the complete clinical team including underserved clinical areas such as dentistry, orthopedics, and OB/GYN, "ThrombosisClinic.com will provide clinicians from primary care to intensive care access to evidence-based strategies that can be immediately employed in practice," said Dr. Timothy Hayes, President of AcademicCME.

The site will centralize the clinician's natural learning actions and simplify their lifelong learning journey. In an age when clinicians face a daily challenge to stay current with new and emerging best practices, the all-new ThrombosisClinic.com will introduce resources and an innovative set of connected learning tools that clinicians need to streamline their information gathering and support practical, lifelong learning.

Recent data suggest that the majority of clinicians are using new social technologies for the express purpose of lifelong learning and professional development. As a result, Brian S. McGowan, PhD, Co-Founder & Chief Learning Officer of ArcheMedX, said, "A key innovation of the all-new ThrombosisClinic.com site is the launch of a series of curriculum-based "Virtual Courses" designed to more effectively educate interdisciplinary teams as they participate in collaborative learning activities." Small, trusted cohorts of learners will engage with faculty and assist each other in completing educational objectives throughout the virtual courses and collaborative learning environment.

Powered by the ArcheMedX Connected Learning Platform, the site will seamlessly connect the virtual courses and new forms of educational content to Elsevier's comprehensive archives of clinical publications, making it simple for clinicians to access, review, share, and apply related educational content to clinical practice. Access to the new Virtual Courses, collaborative learning tools, and other educational activities on ThrombosisClinic.com will be available for registered learners beginning in the second half of 2013.

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,293.58 +27.59 0.16%
S&P 500 2,010.34 -1.02 -0.05%
NASDAQ 4,575.5810 -17.8440 -0.39%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs